145 related articles for article (PubMed ID: 18947972)
1. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression).
Katzav A; Ben-Ziv T; Chapman J; Blank M; Reichlin M; Shoenfeld Y
J Autoimmun; 2008 Dec; 31(4):393-8. PubMed ID: 18947972
[TBL] [Abstract][Full Text] [Related]
2. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.
Katzav A; Solodeev I; Brodsky O; Chapman J; Pick CG; Blank M; Zhang W; Reichlin M; Shoenfeld Y
Arthritis Rheum; 2007 Mar; 56(3):938-48. PubMed ID: 17328071
[TBL] [Abstract][Full Text] [Related]
3. To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system.
Shoenfeld Y
J Autoimmun; 2007; 28(2-3):165-9. PubMed ID: 17382516
[TBL] [Abstract][Full Text] [Related]
4. Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling.
Kapadia M; Bijelić D; Zhao H; Ma D; Stojanovich L; Milošević M; Andjus P; Šakić B
Acta Neuropathol Commun; 2017 Sep; 5(1):70. PubMed ID: 28882191
[TBL] [Abstract][Full Text] [Related]
5. Abnormal olfactory function demonstrated by manganese-enhanced MRI in mice with experimental neuropsychiatric lupus.
Kivity S; Tsarfaty G; Agmon-Levin N; Blank M; Manor D; Konen E; Chapman J; Reichlin M; Wasson C; Shoenfeld Y; Kushnir T
Ann N Y Acad Sci; 2010 Apr; 1193():70-7. PubMed ID: 20398010
[TBL] [Abstract][Full Text] [Related]
6. Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice.
Katzav A; Ben-Ziv T; Blank M; Pick CG; Shoenfeld Y; Chapman J
J Neuroimmunol; 2014 Jul; 272(1-2):10-5. PubMed ID: 24837568
[TBL] [Abstract][Full Text] [Related]
7. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
[TBL] [Abstract][Full Text] [Related]
8. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
9. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus.
Choi MY; FitzPatrick RD; Buhler K; Mahler M; Fritzler MJ
Autoimmun Rev; 2020 Mar; 19(3):102463. PubMed ID: 31927088
[TBL] [Abstract][Full Text] [Related]
10. Antiribosomal antibodies in SLE, infection, and following deliberate immunization.
Elkon KB; Bonfa E; Weissbach H; Brot N
Adv Exp Med Biol; 1994; 347():81-92. PubMed ID: 7976736
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic potential of targeting anti-Ribosomal-P antibody in treating SLE patients with depression.
Blank M; Beinglass I; Shoenfeld Y
Expert Opin Biol Ther; 2007 Sep; 7(9):1283-5. PubMed ID: 17727319
[TBL] [Abstract][Full Text] [Related]
12. Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.
Owolabi RA; Akanmu MA; Adeyemi OI
Neurosci Lett; 2014 Apr; 566():172-6. PubMed ID: 24530380
[TBL] [Abstract][Full Text] [Related]
13. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
14. Effects of co-administration of fluoxetine and risperidone on properties of peritoneal and pleural macrophages in rats subjected to the forced swimming test.
Roman A; Kuśmierczyk J; Klimek E; Rogóż Z; Nalepa I
Pharmacol Rep; 2012; 64(6):1368-80. PubMed ID: 23406747
[TBL] [Abstract][Full Text] [Related]
15. Altered olfactory function in the MRL model of CNS lupus.
Kapadia M; Stanojcic M; Earls AM; Pulapaka S; Lee J; Sakic B
Behav Brain Res; 2012 Oct; 234(2):303-11. PubMed ID: 22796602
[TBL] [Abstract][Full Text] [Related]
16. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
[TBL] [Abstract][Full Text] [Related]
17. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies.
Spezialetti R; Bluestein HG; Peter JB; Alexander EL
Am J Med; 1993 Aug; 95(2):153-60. PubMed ID: 8356981
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological dysfunction induced by anti-ribosomal P protein antibodies injection into the lateral ventricle of the rat brain.
Gaburo N; de Carvalho JF; Timo-Iaria C; Bueno C; Reichlin M; Viana VS; Bonfá E
Lupus; 2017 Apr; 26(5):463-469. PubMed ID: 28394228
[TBL] [Abstract][Full Text] [Related]
20. Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus.
Shi ZR; Tan GZ; Meng Z; Yu M; Li KW; Yin J; Wei KH; Luo YJ; Jia SQ; Zhang SJ; Wu J; Mi XB; Wang L
Arthritis Rheumatol; 2015 Jan; 67(1):193-203. PubMed ID: 25307291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
